Vanderbilt University Medical Center: VICC's Mayer Departing to Take New Role With AstraZeneca
October 29, 2021
October 29, 2021
NASHVILLE, Tennessee, Oct. 29 -- Vanderbilt University Medical Center issued the following news:
After 18 years of service, Ingrid Mayer, MD, MSCI, professor of Medicine and Ingram Professor of Cancer Research, is departing Vanderbilt University Medical Center for a new role as an executive with AstraZeneca.
In December she will become vice president, Global Clinical Head, Breast Cancer, and the head of Breast Cancer Research Strategy at AstraZeneca. Mayer is an interna . . .
After 18 years of service, Ingrid Mayer, MD, MSCI, professor of Medicine and Ingram Professor of Cancer Research, is departing Vanderbilt University Medical Center for a new role as an executive with AstraZeneca.
In December she will become vice president, Global Clinical Head, Breast Cancer, and the head of Breast Cancer Research Strategy at AstraZeneca. Mayer is an interna . . .